Safety and efficacy of neoadjuvant chemotherapy with paclitaxel, carboplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma.

Ryoko TanakaYushi UekiShusuke OhshimaJo OmataYusuke YokoyamaTakeshi TakahashiRyusuke ShodoKeisuke YamazakiKohei OhtakiTakafumi TogashiArata Horii

Published in: International journal of clinical oncology (2024)

NAC using the PCE regimen for patients with locally advanced HNSCC, including cisplatin-ineligible patients, has acceptable toxicity and favorable efficacy.

Keyphrases

locally advanced
neoadjuvant chemotherapy
phase ii study
rectal cancer
squamous cell carcinoma
radiation therapy
end stage renal disease
lymph node
newly diagnosed
prognostic factors
oxidative stress
transcription factor
clinical trial
early stage
metastatic colorectal cancer
placebo controlled
phase iii